Description
BSE updates Enhanced Surveillance Measure framework with new securities additions and stage movements effective September 2, 2025.
Summary
BSE has updated the Enhanced Surveillance Measure (ESM) framework effective September 2, 2025. Two new securities have been added to ESM Stage I, while two existing securities will move to higher ESM stages. No securities are moving out of the ESM framework or to lower stages.
Key Points
- 2 new securities added to ESM Stage I framework
- 2 existing securities moved to higher ESM stages
- No securities removed from ESM framework
- No securities moved to lower ESM stages
- Consolidated list shows 31+ securities currently under various ESM stages
Securities Added to ESM Stage I
- N2N Technologies Ltd (Scrip Code: 512279, ISIN: INE043F01011)
- Titan Biotech Ltd (Scrip Code: 524717, ISIN: INE150C01011)
Securities Moving to Higher ESM Stages
- Kuber Udyog Ltd (Scrip Code: 539408, ISIN: INE594R01018)
- Tamilnadu Steel Tubes Ltd (Scrip Code: 513540, ISIN: INE176E01012)
Regulatory Changes
Enhanced surveillance measures impose additional restrictions on trading including:
- Price bands and position limits
- 100% margin requirements
- Additional disclosure requirements
- Periodic review mechanisms
Compliance Requirements
- Listed companies under ESM must comply with enhanced disclosure norms
- Investors face trading restrictions including margin requirements
- Brokers must ensure compliance with ESM-specific trading rules
Important Dates
- Effective Date: September 2, 2025
- All ESM changes become applicable from market opening on this date
Impact Assessment
The ESM framework affects trading liquidity and investor access to these securities. Securities under ESM face reduced trading volumes due to enhanced margin requirements and price restrictions. This measure aims to protect investors from excessive volatility while maintaining market integrity.
Impact Justification
Affects trading conditions for multiple securities under enhanced surveillance